SecBot SecBot
8-K ·Filed Apr 30, 2026

CI

Cigna Group
BULLISH
Impact 7/10
Horizondays Processed6mo ago SEC0001140361-26-017971
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The beat-and-raise quarter with improving margins and strong Cigna Healthcare performance supports a bullish read-through. Monitor the Pharmacy Benefit Services margin trajectory and the impact of expected client transitions on Evernorth's profitability. The raised guidance (+$0.10) is modest but signals confidence in the diversified portfolio.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$290.33
T+0 close · Apr 30, 2026 · via day close
Latest settled
−0.26%
T+60 · $289.57
Vs SPY
−3.08%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $290.33entry
  2. T+1 · 7mo ago −2.79%α −3.01% · $282.24
  3. T+5 · 6mo ago −2.30%α −4.03% · $283.65
  4. T+20 · 6mo ago −4.50%α −9.73% · $277.25
  5. T+60 · 4mo ago −0.26%α −3.08% · $289.57

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cigna Group reported strong Q1 2026 results with adjusted EPS of $7.79, beating the $7.62 consensus by 2.2%, and total revenue of $68.5B (+5% YoY). The company raised its full-year 2026 adjusted EPS outlook to at least $30.35 (from at least $30.25), driven by strong performance in Cigna Healthcare (pre-tax income +18% YoY) and improved operating efficiency, partially offset by a 28% decline in Pharmacy Benefit Services operating income.

Key Financial Metrics

EPS
$7.79
est $7.62 · +2.2%
Revenue
$68.5B
est $66.2B · +3.5% · +5.0% YoY
Rating
beat

Key Facts

  • Q1 2026 adjusted EPS $7.79 vs consensus $7.62 (beat by 2.2%)
  • Q1 2026 total revenue $68.5B, +5% YoY
  • Full-year 2026 adjusted EPS guidance raised to at least $30.35 (from at least $30.25)
  • Cigna Healthcare pre-tax adjusted income +18% YoY to $1.514B
  • Cigna Healthcare MCR improved to 79.8% from 82.2% YoY
  • Evernorth Health Services adjusted revenue +9% YoY, but pre-tax income only +2%
  • Pharmacy Benefit Services pre-tax income -28% YoY due to lower contributions from large clients
  • SG&A expense ratio improved to 5.4% from 6.4% YoY (adjusted 4.8% from 5.8%)
  • Debt-to-capitalization ratio improved to 42.3% from 43.0% at year-end 2025
  • Total medical customers increased 1% from Dec 2025 to 18.3M

Financial Impact

Q1 2026 adjusted EPS $7.79 vs $7.62 consensus; revenue $68.5B vs $66.2B consensus; guidance raised by $0.10 to at least $30.35

epsrevenueguidanceoperating incomemedical care ratio

Risk Factors

  • Pharmacy Benefit Services pre-tax income declined 28% YoY, indicating competitive pressure in PBM
  • Total pharmacy customers decreased 2% from Dec 2025, reflecting expected client transitions
  • Cigna Healthcare adjusted revenue declined 21% YoY (though +8% ex-HCSC divestiture)
  • Full-year guidance raise of only $0.10 suggests limited upside conviction

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
85% bullish (34 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-017971
Document: ef20071317_8k.htm0001140361-26-017971
Document: 0001140361-26-017971-index-headers.html0001140361-26-017971
Document: 0001140361-26-017971-index.html0001140361-26-017971
Document: 0001140361-26-017971.txt0001140361-26-017971
8-K Data (Synthetic)0001140361-26-017971

Track record

16 reports on CI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $301.48 to $296.27 Now $297.00 −1.49% ▼ −1.73% −5.02% vs SPY
  2. Oct 28, 202619d ago Press Release Neutral 2/10 Entry $298.41 to $301.48 Now $297.00 −0.47% ▲ +1.03% +5.75% vs SPY
  3. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $295.00 to $305.41 Now $297.00 +0.68% ▲ +3.53% +4.24% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $304.37 to $298.28 Now $297.00 −2.42% ▼ −2.00% −1.56% vs SPY
  5. Oct 9, 20265w ago 8-K Neutral 2/10 Entry $283.34 to $298.50 Now $297.00 +4.82% ▲ +5.35% +6.84% vs SPY
  6. Sep 30, 20266w ago 8-K Neutral 4/10 Entry $271.83 to $278.51 Now $297.00 +9.26% ▲ +2.46% +0.54% vs SPY
  7. Sep 3, 202610w ago 144 Neutral 2/10 Entry $286.26 to $280.76 Now $297.00 +3.75% ▼ −1.92% −0.77% vs SPY
  8. Aug 18, 202612w ago 144 Neutral 2/10 Entry $278.50 to $279.32 Now $297.00 +6.64% ▲ +0.29% +0.50% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Entry $273.45 to $273.87 Now $297.00 +8.61% ▲ +0.16% +0.25% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $293.46 to $283.82 Now $297.00 +1.21% ▼ −3.28% −2.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026